Clinical Trial

(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study]

This study is for children who have cystic fibrosis and come down with a pseudomonas lung infection. It will test two different ways of using the drug Aztreonam to see which way works better.

• Respiratory System
• Cystic Fibrosis
• Pseudomonas Aeruginosa